Talking Euretina
Een podcast door Whipsmart Media
60 Afleveringen
-
Episode 39: The Euretina Retinal Medicine Clinical Research Award
Gepubliceerd: 15-11-2023 -
Episode 38: Preview of Euretina Congress 2023
Gepubliceerd: 29-9-2023 -
Episode 37: Blind Faith - How RP patients are being targeted with bad science across the world
Gepubliceerd: 15-9-2023 -
Episode 36: The Ophthalmologica Lecture: Maximilian Pfau
Gepubliceerd: 1-9-2023 -
Episode 35: Treating PCV and Pachychoroid in Different Populations
Gepubliceerd: 15-8-2023 -
Episode 34: The Euretina Lecture: OncoVR
Gepubliceerd: 31-7-2023 -
Episode 33: The Euretina Innovation Summit - All You Need to Know
Gepubliceerd: 3-7-2023 -
Episode 32: Macular Holes and Glaucoma in Myopia
Gepubliceerd: 15-6-2023 -
Episode 31: Featured studies from the Ophthalmologica journal
Gepubliceerd: 18-5-2023 -
Episode 30: Intraocular Lymphoma: An Explainer
Gepubliceerd: 2-5-2023 -
Episode 29: How to get published in Euretina’s Journal, Ophthalmologica
Gepubliceerd: 14-4-2023 -
Episode 28: Diabetic Retinopathy - the latest exciting developments from across the world
Gepubliceerd: 30-3-2023 -
Episode 27: What do we mean by ”macula-off” RRD ... and how soon should we act?
Gepubliceerd: 14-3-2023 -
Episode 26: Tackling Acute Retinal Necrosis in Patients
Gepubliceerd: 1-3-2023 -
Episode 25: What individual patient data can tell us about treating macular holes
Gepubliceerd: 15-2-2023 -
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
Gepubliceerd: 6-2-2023 -
Episode 23: Everything You Need to Know About the New EBO-Euretina Exam
Gepubliceerd: 17-1-2023 -
Episode 22: Women in Retina
Gepubliceerd: 1-12-2022 -
Episode 21: What To Know About The Bad Guy In Myopia: Staphyloma
Gepubliceerd: 17-11-2022 -
Episode 20: A Deep Dive into the MOLES System
Gepubliceerd: 3-11-2022
Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.